The clinical research on serum cystatin-C alteration on stage II chronic kidney disease with gubenquduyishen decoction treatment

Journal of Ethnopharmacology

Volumn 131, Issue 3, 2010, Pages 581-584

  Dong, Feixia ^a,b   Cheng, Jinguo ^b   Lin, Songcang ^c   Hu, Zhen ^d   Chen, Gang ^a   He, Liqun ^a  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese herb; Chronic kidney disease; Cystatin C

Indexed keywords

CHINESE DRUG; CREATININE; CYSTATIN C; GUBENQUDUYISHEN; NITROGEN; UNCLASSIFIED DRUG; UREA;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; UREA NITROGEN BLOOD LEVEL;

BLOOD UREA NITROGEN; CHRONIC DISEASE; CREATININE; CYSTATIN C; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 77956650119     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.07.032     Document Type: Article

References (21)

1. Abrahamson M., Olafsson I., Palsdottir A. Structure and expression of the human cystatin C gene. Biochemical Journal 1990, 268:287-294.
2. Bricon T., Thervet E., Froissart M. Plasma cystatin-C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clinical Chemistry 2000, 46:1206-1207.
3. Coll E., Wirtz O., Heli I. Serum cystatin-C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early impairment. American Journal of Kidney Diseases 2000, 36:29-34.
4. Dong F.X. The clinical observation on powder para-stannum influencing time of the traditional Chinese medicine reserved clusis and level of plasma Cys-C and Scr. Journal of Sichuan of Traditional Chinese Medicine 2003, 21:6-7.
5. Dong F.X., Cheng J.G. The clinical research on plasma Cys-C alteration of chronic renal failure with Qufengyishen tang treatment. Journal of Hubei college of TCM 2003, 5:41-42.
6. Dong F.X., Cheng J.G., Huang W.X. Clinical research on" Guben quduyishen decoction" in treating 60 cases of stage-II chronic renal failure. Journal of Shanghai of TCM 2008, 42:29-30.
7. Grubb A.O. Cystatin C properties and use as diagnostic marker. Advances in Clinical Chemistry 2000, 35:63-99.
8. Grubb A.O., Löfberg H. Human-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:3024-3027.
9. Harmoinen A.P.T., Kouri T.T., Wirta O.R. Evaluation of plasma cystatin-C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clinical Nephrology 1999, 52:363-370.
10. He L.Q., Cai G. The clinical observation of the JIAN-PI-QIN-HUI prescription on spleen deficiency and dampness heat style patients with chronic renal failure. Journal of International Medical Science of China 2005, 14:270-274.
11. He L.Q., Shen P.C., Fu Q. Nephro-protective effect of Kangqianling decoction on chronic renal failure rats. Journal of Ethnopharmacology 2009, 122:367-373.
12. Hu S.J., Fang Q., Liu J.S. Clinical study on intervention of Liuwei dihuang pill on hormonotherapy in treating nephrotic syndrome. Chinese Journal of Integrative Medicine 2005, 25:107-110.
13. Jacobsson B., Lignelid H., Bergerheim U.S. Transthyretin and cystatin-C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995, 26:559-564.
14. Kathrin S., Tom N., Mats F. Performance characteristics of a cystatin-C immunoassay with avian antibodies. Upsala Journal of Medical Sciences 2007, 112:21-37.
15. Kyong J.J., Jinu K., Yong K.P. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-b/Smad2/3 signaling. Food and Chemical Toxicology 2010, 48:522-529.
16. Larsson A., Malm J., Grubb A. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin-C values in mg/L. Scandinavian Journal of Investigation 2004, 64:25-30.
17. Laterza O.F., Price C.P., Scott M.G. Cystatin C: an improved estimator of glomerular filtration rate?. Clinical Chemistry 2002, 48:63-69.
18. Stabuc B., Vrhovec L., Stabuc-Silih M. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clinical Chemistry 2000, 46:193-197.
19. Stefan H.K., Sillce T., Frank P. Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. American Journal of Nephrology 2000, 20:97-102.
20. Tanaka A., Suemaru K., Araki H. A new approach for evaluating renal function and its practical application. Journal of Pharmacological Science 2007, 105:1-5.
21. Young M.S., Jinu K., Ki C.C. Wen-pi-tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice A role for antioxidant enzymes and heat-shock proteins. Journal of Ethnopharmacology 2007, 112:333-340.